icad inc. Working Capital

Working Capital of ICAD for past 10 years: annual, quarterly and twelve month trailing (TTM) including Working Capital growth rates and interactive chart. Working capital, also known as net working capital (NWC), is the difference between a company’s current assets, such as cash, accounts receivable (customers’ unpaid bills) and inventories of raw materials and finished goods, and its current liabilities, such as accounts payable. Net operating working capital is a measure of a company's liquidity and refers to the difference between operating current assets and operating current liabilities. In many cases these calculations are the same and are derived from company cash plus accounts receivable plus inventories, less accounts payable and less accrued expenses. Working capital is a measure of a company's liquidity, operational efficiency and its short-term financial health. If a company has substantial positive working capital, then it should have the potential to invest and grow. If a company's current assets do not exceed its current liabilities, then it may have trouble growing or paying back creditors, or even go bankrupt.


Highlights and Quick Summary

  • Working Capital for the quarter ending March 30, 2021 was $48.1 Million (a 88.25% increase compared to previous quarter)
  • Year-over-year quarterly Working Capital increased by 110.06%
  • Annual Working Capital for 2020 was $25.6 Million (a 146.63% increase from previous year)
  • Annual Working Capital for 2019 was $10.4 Million (a 29.91% increase from previous year)
  • Annual Working Capital for 2018 was $7.98 Million (a -12.74% decrease from previous year)
Visit stockrow.com/ICAD for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Working Capital of icad inc.

Most recent Working Capitalof ICAD including historical data for past 10 years.

Interactive Chart of Working Capital of icad inc.

icad inc. Working Capital for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 $48.1
2020 $25.55 $21.59 $22.9 $11.46 $25.55
2019 $10.36 $12.65 $14.91 $7.02 $10.36
2018 $7.98 $4.54 $6.36 $6.4 $7.98
2017 $9.14 $11.11 $6.54 $7.34 $9.14
2016 $7.08 $8.06 $9.85 $11.08 $7.08
2015 $13.49 $15.57 $14.38 $15.89 $13.49
2014 $22.57 $25.29 $27.83 $28.27 $22.57
2013 $-0.41 $6.51 $6.46 $7.18 $-0.41
2012 $6.89 $8.59 $8.62 $10.99 $6.89
2011 $-1.38 $1.03 $1.98 $7.67 $-1.38
2010 $11.7 $14.71 $15.64 $11.7

Business Profile of icad inc.

Sector: Healthcare
Industry: Health Information Services
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, and image storage and review systems; SecondLook, a machine learning-based cancer detection algorithm that analyzes 2D full-field digital mammography images to identify and mark suspicious masses and calcifications; and automated density assessment solutions, which provides automated, consistent, and standardized density assessment. It also offers ProFound AI, a deep-learning algorithm designed to detect malignant soft-tissue densities and calcifications in digital breast tomosynthesis; ProFound AI Risk, a tool that provides breast cancer risk estimation based on a screening mammogram; and magnetic resonance imaging applications, a tool to detect breast and prostate cancer. In addition, the company offers VeraLook, a solution designed to support the detection of colonic polyps in conjunction with CT Colonography. Further, it provides Xoft Axxent electronic brachytherapy systems for the treatment of early stage breast, non-melanoma skin, and gynecological cancers to university research and community hospitals, cancer care clinics, veterinary facilities, and dermatology offices. The company serves healthcare centers through direct sales organizations, as well as through various original equipment manufacturer partners, distributors, and resellers. It also exports its products in Europe, Taiwan, Canada, China, and internationally. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.